The £5m round was led by YFM Equity Partners to accelerate global growth and platform development.
"Our partnership with YFM has been instrumental in driving Vypr’s growth and there is no clearer sign of potential than a major investor more than doubling its backing. With an excellent team here, a unique product roadmap, and enormous global opportunity, we can now deliver the next phase of our strategy and bring even greater value to our customers globally."
The biotechnology firm raised fresh capital to accelerate growth in American and European markets and complete new laboratory facilities.
"Over the last year we’ve demonstrated the market for novel and improved in vitro testing methods and expanded our customer base as well as the Aelius team. Along with our move to our new premises, this latest funding will enable us to accelerate our growth in international markets, particularly in the US."
The bottled cocktail producer has secured capital to scale its operations and expand its market reach.
"Tom and Paul delivered an excellent pitch with a clear route to market and unique positioning. The ACG team were delighted to be able to present this brilliant company to the membership and we’re excited to them to scale and grow"